Profile
Xue Dan Wu is currently Chief Executive Officer & Executive Director at Pharmesis International Ltd. since 2017 and Chairman at Sichuan Longlife Pharmaceutical Co. Ltd. Mr. Wu was Chairman & General Manager at Chengdu Kinna Pharmaceutical Co. Ltd. Mr. Wu completed an undergraduate degree at Union University in 1987.
Xue Dan Wu active positions
| Companies | Position | Start |
|---|---|---|
| PHARMESIS INTERNATIONAL LTD. | Chief Executive Officer | 31/12/2017 |
Sichuan Longlife Pharmaceutical Co., Ltd.
Sichuan Longlife Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Develops, manufactures and sells traditional Chinese medicines | Chairman | - |
Former positions of Xue Dan Wu
| Companies | Position | End |
|---|---|---|
Chengdu Kinna Pharmaceutical Co., Ltd.
Chengdu Kinna Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medicines & health tonic products | Chief Executive Officer | - |
Training of Xue Dan Wu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Pharmesis International Ltd.
Pharmesis International Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in the manufacturing and distributing pharmaceutical products | Health Technology |
Union University
Union University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chengdu Kinna Pharmaceutical Co., Ltd.
Chengdu Kinna Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medicines & health tonic products | Health Technology |
Sichuan Longlife Pharmaceutical Co., Ltd.
Sichuan Longlife Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Develops, manufactures and sells traditional Chinese medicines | Health Technology |
- Stock Market
- Insiders
- Xue Dan Wu
















